Doç. Dr. MÜÇTEBA ENES YAYLA

Yayın Ağı

Makaleler 46

1. Deep Learning Performance in Analyzing Nailfold Videocapillaroscopy Images in Systemic Sclerosis

YAYLA M. E., AYDIN A., KILIÇASLAN M., KALKAN M., GÜZEL M. S., Shikhaliyeva A., et al.

DIAGNOSTICS , cilt.15, sa.22, 2025 (SCI-Expanded, Scopus)

2. Is the Development of Hypo-Gammaglobulinemia Associated with Better Treatment Response in Patients with Rheumatoid Arthritis Using Rituximab?

Aydemir Guloksuz E. G., Sezer S., Sahin Eroglu D., Colak S., Kelesoglu Dincer A. B., Yayla M. E., et al.

Journal of clinical medicine , cilt.14, sa.19, 2025 (SCI-Expanded)

3. Malignancy-associated risk factors in patients with systemic sclerosis

Baysal S., Şahin D., SEZER S., YAYLA M. E., USLU E., ATEŞ A., et al.

Journal of Scleroderma and Related Disorders , cilt.10, sa.3, ss.518-522, 2025 (ESCI)

4. Ultrasonographic evaluation of hand and wrist joints in patients with systemic sclerosis

Ermancık Z., YAYLA M. E., İlbay A., GÖVEÇ GIYNAŞ N., SEZER S., USLU E., et al.

Journal of Scleroderma and Related Disorders , cilt.10, sa.3, ss.510-517, 2025 (ESCI)

5. Impact of age at disease onset on clinical manifestations and prognosis in systemic lupus erythematosus Sistemik lupus eritematozusta hastalık başlangıç yaşının klinik belirtiler ve prognoz üzerindeki etkisi

Şahin D., Bulat B., USLU E., GÖVEÇ GIYNAŞ N., TURHAN G., Kader M., et al.

Journal of Turkish Society For Rheumatology , cilt.17, sa.2, ss.60-67, 2025 (Scopus)

6. Evaluation of performance of the Still Activity Score for assessment of Adult-onset Still's Disease: Comparative study with Systemic Feature Score and Modified Pouchot-Activity Score Evaluación del desempeño de la puntuación de actividad de Still en la valoración de la enfermedad de Still de inicio en la adultez: un estudio comparativo con la puntuación de las características sistémicas y la puntuación de la actividad modificada de Pouchot

Uslu E., Yayla M. E., Şahin Eroğlu D., Atmaca-Haktaniyan B., Göveç Gıynaş N., Yılmaz R., et al.

Reumatologia Clinica , cilt.21, sa.2, 2025 (ESCI)

7. Rheumatoid Arthritis-Related Lung Disease and Its Association With Mortality

Şahin Eroğlu D., Çolaklar A., Baysal S., Torgutalp M., Baygül A., Sezer S., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.30, sa.5, ss.177-182, 2024 (SCI-Expanded, Scopus)

8. Serum leukemia inhibitory factor (LIF) levels in patients with Takayasu's and Giant cell arteritis: A cross-sectional study Niveles séricos del factor inhibidor de la leucemia en pacientes con arteritis de Takayasu y de células gigantes, un estudio transversal

Aksoy R., TURGAY T. M., YILMAZ R., SEZER S., YAYLA M. E., USLU E.

Reumatologia Clinica , cilt.20, sa.6, ss.287-290, 2024 (ESCI)

9. The Performance of 2023 American College of Rheumatology (ACR) / European Alliance of Associations for Rheumatology (EULAR) Antiphospholipid Syndrome Classification Criteria in a Real-World Rheumatology Department

USTA A., YAYLA M. E., USLU E., SEZER S., US E., ATEŞ A., et al.

Mediterranean Journal of Hematology and Infectious Diseases , cilt.16, sa.1, 2024 (SCI-Expanded)

10. Are there differences in the clinical and laboratory features of patients with seronegative primary Sjögren's syndrome?

Yayla M. E., Aksoy R., Uslu E., Karaman Z., Yılmaz R., Ilbay A., et al.

Turkish journal of medical sciences , cilt.54, sa.5, ss.956-962, 2024 (SCI-Expanded)

11. Investigation of COVID-19 Vaccination and Disease Status in Behçet’s Patients

Yılmaz R., Sezer S., İlbay A., Göveç Gıynaş N., Aydemir Gülöksüz E. G., Gaydan A., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.76, sa.3, ss.206-212, 2023 (Hakemli Dergi)

12. The factors predicting development of serious infections in ANCA-associated vasculitis

USLU YURTERİ E., Sezer S., Torgutalp M., YAYLA M. E., Eroglu D. S., Okatan I. E., et al.

Sarcoidosis Vasculitis and Diffuse Lung Diseases , cilt.40, sa.2, 2023 (SCI-Expanded, Scopus)

13. Frequency of Helicobacter pylori in Patients With Rheumatoid Arthritis Whose Methotrexate Was Stopped Due to Gastrointestinal Intolerance

Aydemir Guloksuz E. G., Sezer S., YAYLA M. E., Sahin Eroglu D., USLU YURTERİ E., Kelesoglu Dincer A. B., et al.

Journal of Clinical Rheumatology , cilt.29, sa.4, ss.177-182, 2023 (SCI-Expanded)

14. Audiological involvement in patients with systemic sclerosis

Turan K., Yayla M. E., Arslan M., Tokgoz Yilmaz S., Okatan E., Turgay M., et al.

MODERN RHEUMATOLOGY , cilt.32, sa.6, ss.1094-1101, 2022 (SCI-Expanded, Scopus)

15. Indications and risk factors for hospitalization in patients with primary Sjogren syndrome: experience from a tertiary center in Turkey

Yayla M. E., ŞAHİN EROĞLU D., USLU YURTERİ E., Dincer A. B. K., Sezer S., AYDEMİR GÜLÖKSÜZ E. G., et al.

CLINICAL RHEUMATOLOGY , cilt.41, sa.5, ss.1457-1463, 2022 (SCI-Expanded, Scopus)

16. Fetal exposure to canakinumab: a report of three pregnancies

Ilgen U., Eyupoglu S., Yayla M. E., KÜÇÜKŞAHİN O.

CLINICAL RHEUMATOLOGY , cilt.41, sa.4, ss.1261-1263, 2022 (SCI-Expanded, Scopus)

17. Prognostic factors for relapse and poor outcome in neuro-Behcet's syndrome: results from a clinical long-term follow-up of a single centre

ŞAHİN EROĞLU D., Torgutalp M., YÜCESAN C., Sezer S., Yayla M. E., BOYVAT A., et al.

JOURNAL OF NEUROLOGY , cilt.269, sa.4, ss.2046-2054, 2022 (SCI-Expanded, Scopus)

18. Analysis of vascular involvement in 460 patients with Behc , et's syndrome: Clinical characteristics and associated factors

Torgutalp M., Şahin Eroğlu D., Sezer S., Yayla M. E., Karataş G., Uslu Yurteri E., et al.

JOINT BONE SPINE , cilt.89, sa.2, 2022 (SCI-Expanded, Scopus)

19. Can Subclinical Atherosclerosis Be Assessed More Precisely in Behcet Syndrome Patients by Using a Particular Cutoff Value for Carotid Intima Media Thickness?

Uslu Yurteri E., Üstüner E., Torgutalp M., Yayla M. E., Okatan I. E., Sezer S., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.28, sa.1, 2022 (SCI-Expanded, Scopus)

20. Interstitial Lung Disease in Systemic Sclerosis: A Single-center Retrospective Analysis

Yayla M. E., Balci G., USLU YURTERİ E., ŞAHİN EROĞLU D., Dincer A. B. K., AYDEMİR GÜLÖKSÜZ E. G., et al.

CURRENT RHEUMATOLOGY REVIEWS , cilt.18, sa.2, ss.150-156, 2022 (ESCI, Scopus)

21. Causes of severe infections in patients with systemic sclerosis and associated factors

YAYLA M. E., USLU YURTERİ E., USLU YURTERİ E., Sahin D., Sezer S., Dincer A. B. K., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.6, ss.1881-1888, 2022 (SCI-Expanded, Scopus, TRDizin)

22. RITUXIMAB EXPERIENCE FROM A SINGLE CENTRE FOR PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE

Eroglu D. S., Colaklar A., Baysal S., Torgutalp M., Baygul A., YAYLA M. E., et al.

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , cilt.39, sa.3, 2022 (SCI-Expanded, Scopus)

23. Patients characteristics in Behcet's Syndrome and their associations with major organ involvement: a single-centre experience of 2118 cases

Torgutalp M., Eroglu D. S., Sezer S., Yayla M. E., Karatas G., Ozel E. M., et al.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , cilt.51, sa.1, ss.50-58, 2022 (SCI-Expanded, Scopus)

24. Clinical characteristics of pulmonary artery involvement in patients with Behcet's syndrome: single-centre experience of 61 patients

ŞAHİN EROĞLU D., Torgutalp M., Baysal S., ÇOLAKLAR A., Sezer S., Yayla M. E., et al.

CLINICAL RHEUMATOLOGY , cilt.40, sa.10, ss.4127-4134, 2021 (SCI-Expanded, Scopus)

25. The Importance of Lower Extremity Vein Wall Thickness in Patients with Behcet's Syndrome

Kocabay H. E., YAYLA M. E., ÜSTÜNER E., Yurteri E. U., Guloksuz E. A., Sezer S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.73, ss.3915-3917, 2021 (SCI-Expanded)

26. CLINICAL CHARACTERISTICS OF THE PULMONARY ARTERY INVOLVEMENT IN PATIENTS WITH BEHCET'S SYNDROME: A SINGLE-CENTRE EXPERIENCE OF 61 PATIENTS

Eroglu D. S., Torgutalp M., Baysal S., Colaklar A., Sezer S., Yayla M. E., et al.

ANNALS OF THE RHEUMATIC DISEASES , ss.949-950, 2021 (SCI-Expanded)

27. Serum-Beta-2-Mikroglobulin-level bei Patienten mit rheumatoider Arthritis und ihre Beziehung zur Krankheitsaktivitat: Kann es als Krankheitsaktivitatsmarker verwendet werden?

Dincer A. B. K., Torgutalp M., Yayla M. E., AYDEMİR GÜLÖKSÜZ E. G., Sezer S., USLU YURTERİ E., et al.

AKTUELLE RHEUMATOLOGIE , cilt.46, sa.3, ss.297-304, 2021 (SCI-Expanded, Scopus)

28. Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels

Torgutalp M., Yayla M. E., Eroglu D. S., Dincer A. B. K., Yurteri E., Okatan I. E., et al.

Mediterranean Journal of Rheumatology , cilt.32, sa.1, ss.56-65, 2021 (Scopus) Sürdürülebilir Kalkınma

29. Share Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels.

TORĞUTALP M., YAYLA M. E., ŞAHİN EROĞLU D., KELEŞOĞLU DİNÇER A. B., USLU YURTERİ E., OKATAN İ. E., et al.

MEDITERRANEAN JOURNAL OF RHEUMATOLOGY (MJR) , cilt.32, sa.1, ss.56-65, 2021 (Scopus)

30. High mobility group box-1 levels may be associated with disease activity of Behcet's disease

Donmez Guler D., Kelesoglu Dincer A. B., KARAHAN Z. C., Guler H. S., Yayla M. E., Sezer S., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.5, ss.2690-2697, 2021 (SCI-Expanded, Scopus, TRDizin)

31. Early onset primary Sjogren syndrome, clinical and laboratory characteristics

Yayla M. E., Karaman Z., Torgutalp M., Dincer A. B. K., AYDEMİR GÜLÖKSÜZ E. G., Sezer S., et al.

CLINICAL RHEUMATOLOGY , cilt.39, sa.9, ss.2689-2696, 2020 (SCI-Expanded, Scopus)

32. Romatoid artrit hastalarında serum gebelikle ilişkiliplazma protein-A düzeylerinin incelenmesi

Torgutalp M., DOĞAN Ö., Yayla M. E., Eroğlu D. Ş., Dinçer A. B. K., SEZER S., et al.

Ulusal Romatoloji Dergisi , cilt.12, sa.2, ss.45-50, 2020 (Hakemli Dergi)

33. İdiyopatik retroperitoneal fibrozis: 17 olguluk tek merkez deneyimi

Keleşoğlu Dinçer A. B., Sezer S., Aydemir Gülöksüz E. G., Yayla M. E., Torgutalp M., Turgay T. M., et al.

Ulusal Romatoloji Dergisi , cilt.12, sa.1, ss.22-26, 2020 (Hakemli Dergi)

34. Serum Interleukin 35 Levels in Systemic Sclerosis and Relationship With Clinical Features

Yayla M. E., Torgutalp M., Okatan I. E., USLU YURTERİ E., KÜÇÜKŞAHİN O., Dincer A. B. K., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.26, sa.3, ss.83-86, 2020 (SCI-Expanded, Scopus)

35. Vascular Involvement in Behcet's Syndrome May be Associated with Subclinical Atherosclerosis

USLU YURTERİ E., ÜSTÜNER E., Torgutalp M., Yayla M. E., Okatan I. E., Dincer A. B. K., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded)

36. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus

Ilgen U., Yayla M. E., Ates A., Okatan I. E., Yurteri E., Torgutalp M., et al.

LUPUS , sa.4, ss.665-669, 2018 (SCI-Expanded, Scopus)

37. A GOOD MIMIC: PMR - IS PMR THE ACCURATE DIAGNOSIS? A SINGLE-CENTER STUDY

Aydin T., Isikoglu B. D., Koc O., Dincer A. B. K., Torgutalp M., Yayla M. E., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.1, 2018 (SCI-Expanded)

38. A Rare Clinical Presentation of Behçet’s Disease with Life-Threatening Extensive Multiple Thrombosis and Recurrent Cardiac Arrest

Shimbori N., YAYLA M. E., YILDIZ A. E., Keleş Karahacıoğlu D., DÜZGÜN N.

Türkiye Klinikleri Journal of Case Reports , cilt.26, sa.3, ss.161-165, 2018 (Hakemli Dergi)

39. TAKAYASU'S ARTERITIS: EXPERIENCE OF A SINGLE TERTIARY CENTER

Dincer A. B. K., Torgutalp M., Guloksuz E. G. A., Yurteri E. U., Yayla M. E., Okatan I. E., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , sa.1, 2018 (SCI-Expanded)

40. An analysis of the relationship between autoantibodies and clinical findings in patients with systemic sclerosis

Yayla M. E., Ilgen U., Duzgun N.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.48, sa.1, ss.10-15, 2018 (SCI-Expanded, Scopus, TRDizin)

41. Anti-angiotensin II type 1 receptor autoantibodies (AT(1)R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations

Ilgen U., Yayla M. E., Duzgun N.

RHEUMATOLOGY INTERNATIONAL , cilt.37, sa.4, ss.593-598, 2017 (SCI-Expanded, Scopus)

42. Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis

Ilgen U., Yayla M. E., Duzgun N.

CLINICAL RHEUMATOLOGY , cilt.36, sa.2, ss.367-372, 2017 (SCI-Expanded, Scopus)

43. RAYNAUD FENOMENİ İLE BAŞVURAN HASTALAR İLE BAĞ DOKU HASTALIĞI OLAN HASTALARIN KAPİLLOROSKOPİK VE LABORATUVAR ÖZELLİKLERİNİN KARŞILAŞTIRILMASI

TORĞUTALP M., OKATAN İ. E., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., ATEŞ A., TURGAY T. M., et al.

RAED DERGİSİ , cilt.8, ss.56, 2016 (Hakemli Dergi)

44. ANTİFOSFOLİPİD ANTİKOR BİRLİKTELİĞİ OLAN VE OLMAYAN SİSTEMİK LUPUS ERİTEMATOZUSLU HASTALARIN AYIRDEDİCİ KLİNİK VE LABORATUVAR ÖZELLİKLERİ

YAYLA M. E., İLGEN U., OKATAN İ. E., USLU YURTERİ E., TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., et al.

RAED DERGİSİ , cilt.8, ss.142, 2016 (Hakemli Dergi)

45. PULMONER TUTULUMLU PRİMER SİSTEMİK SKLEROZDA SERUM PROKALSİTONİN DÜZEYİ ENFEKSİYÖZ PULMONER HASTALIKLARDAN AYIRDETTİRİCİ MİDİR

OKATAN İ. E., KINIKLI S., TORĞUTALP M., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., ATEŞ A., et al.

RAED DERGİSİ , cilt.8, ss.75-76, 2016 (Hakemli Dergi)

46. ATEŞİN NADİR BİR NEDENİ MEZENTERİK PANNİKÜLİT

KELEŞOĞLU DİNÇER A. B., OKATAN İ. E., TORĞUTALP M., YAYLA M. E., KINIKLI G., TURGAY T. M., et al.

RAED DERGİSİ , cilt.8, ss.106-107, 2016 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 15

1. Akut Eozinofilik Miyokardit ile Tanı Alan Eozinofilik Garnülomatozis Polianjitis Olgusu

MAHMUTOĞLU Y., SEZER S., YAYLA M. E., USLU E., ATEŞ A., TURGAY T. M.

Ankara Romatoloji Toplantısı 2024. 6-8 Eylül 2024 Sapanca Türkiye, Sakarya, Türkiye, 6 - 08 Eylül 2024, (Özet Bildiri)

2. EVALUATION OF CLINICAL CHARACTERISTICS OF BEHÇET SYNDROME PATIENTS WITH GASTROINTESTINAL INVOLVEMENT: A SINGLE CENTER EXPERIENCE FROM TURKEY

USLU E., SEZER S., İLBAY A., GÖVEÇ GIYNAŞ N., GAYDAN A., MAHMUTOĞLU Y., et al.

EULAR 2024 congress, Avusturya, 12 Haziran 2024, cilt.83, ss.1250, (Özet Bildiri)

3. CENTRAL NERVOUS SYSTEM INVOLVEMENT IN PRIMARY SJÖGREN’S SYNDROME: A SINGLE CENTER EXPERIENCE FROM TURKEY

KARAMAN ONGUN Z., YAYLA M. E., SEZER S., İLBAY A., GÖVEÇ GIYNAŞ N., GAYDAN A., et al.

EULAR 2024 congress, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1698-1699, (Özet Bildiri)

4. Characteristics of Idiopathic Inflammatory Myopathy Patients with Interstitial Lung Disease: Results of A Single-Center From Turkey

İLBAY A., USLU E., GÖVEÇ GIYNAŞ N., YAYLA M. E., ŞAHİN EROĞLU D., GAYDAN A., et al.

EULAR 2024 congress, Avusturya, 12 Haziran 2024, cilt.83, ss.1378, (Özet Bildiri)

5. KARDİYAK TAMPONAD GELİŞEN SİSTEMİK SKLEROZ HASTASI: OLGU SUNUMU

Mahmutoğlu Y., Yayla M. E., Ateş A., Turgay T. M.

SİSTEMİK SKLEROZ SEMPOZYUMU-4, Ankara, Türkiye, 19 - 21 Nisan 2024, ss.45-46, (Tam Metin Bildiri)

6. The Importance of Lower extremity vein wall thickness in patients with Behcet's Syndrome

Kocabay H. E., Yayla M. E., Üstüner E., Uslu Yurteri E., Aydemir Gülöksüz E. G., Sezer S., et al.

American College of Rheumatology Meeting Abstracts, Washington, Amerika Birleşik Devletleri, 03 Kasım 2021, (Özet Bildiri)

7. Romatoid artrit ilişkili akciğer hastalığı prevalansı ve mortalite ile ilişkili faktörler: Tek merkez deneyimi

ŞAHİN EROĞLU D., ÇOLAKLAR A., Baysal S., TORĞUTALP M., BAYGÜL A., SEZER S., et al.

XXI. Ulusal Romatoloji Kongresi 29 Eylül-3 Ekim 2021, Antalya, Antalya, Türkiye, 29 Eylül - 03 Ekim 2021, (Özet Bildiri)

8. ANCA ilişkili vaskülitlerde enfeksiyon riski

USLU YURTERİ E., SEZER S., TORĞUTALP M., OKATAN İ. E., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., et al.

20. Ulusal Romatoloji Kongresi 16-20 Ekim 2019 Antalya, Antalya, Türkiye, 16 - 20 Ekim 2019, (Özet Bildiri)

9. BEHÇET HASTALARINDA SERUM CALPROTECTİN DÜZEYİ İLE KLİNİK VE LABORATUVAROLARAK DEĞERLENDİRİLEN HASTALIK AKTİVİTE PARAMETRELERİ ARASINDAKİİLİŞKİNİN İNCELENMESİ

TORĞUTALP M., KELEŞOĞLU DİNÇER A. B., Yayla M. E., AYDEMİR GÜLÖKSÜZ E. G., USLU YURTERİ E., OKATAN İ. E., et al.

19. Ulusal Romatoloji Kongresi, Türkiye, 26 - 30 Eylül 2018, (Özet Bildiri)

10. BEHÇET SENDROMUNDA VASKÜLER TUTULUM VE SUBKLİNİK ATEROSKLEROZARASINDAKİ İLİŞKİ

USLU YURTERİ E., ÜSTÜNER E., TORĞUTALP M., Yayla M. E., OKATAN İ. E., KELEŞOĞLU DİNÇER A. B., et al.

19. Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, (Özet Bildiri)

11. AB1131 Il-33, a novel cytokine for fmf? how is it related with disease pathogenesis?

KELEŞOĞLU DİNÇER A. B., GÜLÖKSÜZ E. G., TORĞUTALP M., YAYLA M. E., USLU YURTERİ E., SEZER S., et al.

EULAR 201/8, Amsterdam, Hollanda, 13 - 16 Haziran 2018, (Özet Bildiri)

12. THU0103 Evaluation of serum Β-2 microglobulin levels and its relationship with disease activity in rheumatoid arthritis

KELEŞOĞLU DİNÇER A. B., TORĞUTALP M., GÜLÖKSÜZ E. G., YAYLA M. E., USLU YURTERİ E., OKATAN İ. E., et al.

EULAR 2018, Amsterdam, Hollanda, 13 - 16 Haziran 2018, (Özet Bildiri)

13. AB0734 Serum il-35 levels in systemic sclerosis and relationship with clinical features

YAYLA M. E., TORĞUTALP M., OKATAN İ. E., USLU YURTERİ E., KÜÇÜKŞAHİN O., KELEŞOĞLU DİNÇER A. B., et al.

EULAR 2018, Amsterdam, Hollanda, 13 - 16 Haziran 2018, (Özet Bildiri)

14. AB0218 Correlation of gray scale and power doppler ultrasonography with clinical evaluation in rheumatoid arthritis

OKATAN İ. E., TORĞUTALP M., YAYLA M. E., KELEŞOĞLU DİNÇER A. B., USLU YURTERİ E., ATEŞ A., et al.

Annual European Congress of Rheumatology, EULAR 2017, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1124, (Özet Bildiri)

15. SYSTEMIC LUPUS ERYTHEMATOSUS WITH AND WITHOUT ANTIPHOSPHOLIPID ANTIBODIES DISCRIMINATIVE CLINICAL LABORATORY FEATURES

İLGEN U., ATEŞ A., YAYLA M. E., USLU YURTERİ E., TURGAY T. M., KINIKLI G.

15.INTERNATIONAL CONGRESS ON ANTIPHOSPHOLLIPID ANTIBODIES, 21 - 24 Eylül 2016, (Özet Bildiri)

Metrikler

Yayın

155

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

220

H-İndeks (WoS)

Atıf (Scopus)

220

H-İndeks (Scopus)

Atıf (Scholar)

151

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Sobiad)

H-İndeks (Sobiad)

Atıf (Diğer Toplam)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler